Abstracts

820 – Cytomegalovirus Shedding in Brazilian Pregnant Women Living With HIV and CMV Infection in Infants

Background Cytomegalovirus (CMV) shedding among CMV-seropositive women living with HIV (WLHIV) on antiretroviral therapy (ART)—and its impact on infant CMV infection in non-breastfeeding settings—remains unclear. We aimed to assess maternal CMV shedding in urine from pregnancy through six weeks postpartum, determining the timing and incidence of infant CMV transmission through 12 months of age. Potential…

563 – Discordance of HIV Drug Resistance and Clinical Outcomes in Kenyan Youth With Perinatal HIV

Background HIV drug resistance testing informs regimen design, but some clinical outcomes remain unexplained. Discordance between resistance findings and clinical outcomes challenges interpretation algorithms, especially critical for adolescents and young adults (youth) in resource-limited settings. Methods We followed Kenyan youth with perinatal HIV at Academic Model Providing Access to Healthcare (AMPATH) every 6 months for…

1041 – Potential Impact of DoxyPEP and Decreased STI Screening & Partner Treatment on Antibiotic Use in MSM

Background Some public health authorities are advocating the discontinuation of routine gonorrhea (GC) and chlamydial (CT) screening and the empiric treatment sex partners of persons with GC and CT as measures to decrease antimicrobial use. DoxyPEP use is rising rapidly among MSM. We estimated how changes in STI screening, empiric treatment of partners, and doxyPEP…

599 – Simple Adiposity Measures Identify MASLD in People With HIV: Results From a US Multicenter Cohort

Background About 40% of people with HIV (PWH) have metabolic dysfunction-associated steatotic liver disease (MASLD), but simple tools for risk stratification in the clinic do not exist. BMI is limited by poor differentiation of adiposity from lean mass and variable performance by race. We evaluated whether low-cost adiposity indices are associated with MASLD in PWH…

872 – Implementation of a Mental Health Intervention for Youth With HIV in Kenya

Background Adolescents and young adults living with HIV (YLH) are disproportionately vulnerable to depression, affecting engagement in care and overall well-being. Cognitive behavioral interventions may improve mental health and HIV care outcomes. Methods We conducted cognitive behavioral therapy (CBT) as part of a multi-component intervention in a cluster randomized trial assigning Kenyan YLH to different…

874 – Primary Outcomes of SYV (Voice of Youth) Mental Health Intervention: A Randomized Trial in Tanzania

Background Young people with HIV (YPWH) experience increased morbidity and mortality compared to uninfected peers. Adolescence is a critical developmental stage with unique challenges faced by YPWH related to peer groups, stigma, disclosure, and emerging mental disorders that can result in worse HIV and mental health (MH) outcomes. This abstract reports the primary outcomes of…

656 – HIV Infection and the Burden of Subclinical Atherosclerosis and High-Risk Carotid Plaques

Background Person with HIV (PWH) are at increased risk for cardiovascular disease, yet data on subclinical atherosclerosis, particularly carotid plaque burden and features, remain limited. We aimed to compare the prevalence, characteristics, and clinical correlates of carotid plaques between PWH and HIV-negative individuals.  Methods  In this cross-sectional study conducted at the Shanghai Public Health Clinical…

657 – Improved Longitudinal Adherence to ART in Virally Suppressed PWH Reduces Serious Non-AIDS Events

Background Serious non-AIDS events (SNAEs) are steadily increasing, in particular cardiovascular disease (CVD) and death. People with HIV (PWH) on antiretroviral therapy (ART) develop SNAEs earlier and with less traditional risk factors compared to their counterparts without HIV, despite viral suppression. Risk models using cardiovascular biomarkers showed that improved ART adherence beyond what is needed for…